Internal Medicine, Medical Oncology · Kingsport, TN
NPI
1992993760
Since 2007
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
4 Sheridan Sq Ste 102
Kingsport, TN, 37660
Phone (423) 588-7140
Groups this clinician bills Medicare through
Medicare paid, 2024
$402K
22,890 services
Medicare patients, 2024
326
Average age 74
Drug cost, 2024
$2.9M
1,352 prescriptions
Company payments, 2025
$3,205
From 39 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kanishka Chakraborty was code 36415 (venipuncture blood collection), 169 times for 76 patients. In total Kanishka Chakraborty billed 22,890 services in 97 codes, and Medicare paid $402K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-07-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 36415 Venipuncture Blood Collection | Office | 169 | 76 | $8.65 | $1,462 |
| 99214 Office E&M - Established | Office | 165 | 146 | $93.70 | $15K |
| 85025 Blood Count | Office | 157 | 70 | $7.61 | $1,195 |
| 99215 Office E&M - Established | Facility | 118 | 62 | $91.93 | $11K |
| 80053 Clinical Chemistry | Office | 113 | 53 | $10.35 | $1,170 |
| 99215 Office E&M - Established | Office | 80 | 40 | $135.26 | $11K |
| 96367 Intravenous Infusion, Hydration | Office | 62 | 13 | $20.75 | $1,286 |
| 82784 Immunoassay | Office | 50 | 14 | $9.11 | $456 |
| 96413 Chemotherapy Administration | Office | 45 | 11 | $92.77 | $4,175 |
| 83521 Immunoassay | Office | 44 | 18 | $16.93 | $745 |
| 99214 Office E&M - Established | Facility | 44 | 43 | $52.31 | $2,302 |
| 99205 Office E&M - New | Office | 37 | 37 | $164.85 | $6,099 |
| 99223 Hospital E&M - Initial | Facility | 25 | 24 | $129.36 | $3,234 |
| 83615 Clinical Chemistry | Office | 21 | 21 | $5.92 | $124 |
| 99205 Office E&M - New | Facility | 19 | 19 | $125.91 | $2,392 |
By year: 2022 $71K for 627 services; 2023 $49K for 499 services; 2024 $402K for 22,890 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 169 | 76 | $8.65 | $1,462 |
| 85025 Blood Count | 157 | 70 | $7.61 | $1,195 |
| 80053 Clinical Chemistry | 113 | 53 | $10.35 | $1,170 |
| 82784 Immunoassay | 50 | 14 | $9.11 | $456 |
| 83521 Immunoassay | 44 | 18 | $16.93 | $745 |
| 83615 Clinical Chemistry | 21 | 21 | $5.92 | $124 |
| 82728 Clinical Chemistry | 17 | 15 | $13.36 | $227 |
| 86334 Immunoassay | 16 | 14 | $21.89 | $350 |
| 84165 Clinical Chemistry | 15 | 13 | $10.53 | $158 |
Medicare prescription drug claims, 2024
In 2024, the drug Kanishka Chakraborty prescribed most often to Medicare patients was Dexamethasone, with 80 prescriptions and refills. In total Kanishka Chakraborty wrote 1,352 Medicare prescriptions that cost $2.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Dexamethasone Generic | 80 | 86 | 42 | $1,205 |
| Prochlorperazine Maleate Generic | 79 | 81 | 46 | $1,457 |
| Ondansetron Hcl Generic | 74 | 74 | 47 | $867 |
| Anastrozole Generic | 51 | 120 | 17 | $494 |
| Valacyclovir Valacyclovir Hcl | 46 | 75 | 13 | $2,426 |
| Eliquis Apixaban | 43 | 51 | Under 11 | $29K |
| Pregabalin Generic | 42 | 42 | Under 11 | $289 |
| Duloxetine Hcl Generic | 41 | 73 | 13 | $696 |
| Pantoprazole Sodium Generic | 32 | 56 | Under 11 | $236 |
| Letrozole Generic | 31 | 89 | Under 11 | $726 |
| Lenalidomide Generic | 31 | 31 | Under 11 | $364K |
| Calquence Acalabrutinib Maleate | 30 | 30 | Under 11 | $369K |
| Oxycodone Hcl Generic | 27 | 27 | 17 | $309 |
| Prednisone Generic | 27 | 29 | 12 | $121 |
| Levofloxacin Generic | 26 | 26 | 11 | $145 |
Brand drugs: - claims; generic drugs: 1,100 claims; opioid claims: 37.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kanishka Chakraborty $3,205 ($3,205 in general payments such as food, travel and fees) from 39 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $364.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 18 | $364 |
| Janssen Biotech, Inc. JNJ | 14 | $303 |
| Regeneron Healthcare Solutions, Inc. REGN | 7 | $213 |
| Novartis Pharmaceuticals Corporation NVS | 11 | $213 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 8 | $169 |
| Merck Sharp & Dohme LLC MRK | 6 | $154 |
| E.R. Squibb & Sons, L.L.C. BMY | 8 | $154 |
| Genentech USA, Inc. ROG.SW | 6 | $110 |
| Gilead Sciences, Inc. GILD | 5 | $104 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 5 | $101 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.